AINewsnow

‘Bespoke’ mRNA vaccine significantly reduces risk of melanoma recurrence or death, clinical trial shows | First successful phase 3 trial of mRNA cancer vaccine

Coverage of "‘Bespoke’ mRNA vaccine significantly reduces risk of melanoma recurrence or death, clinical trial shows | First successful phase 3 trial of mRNA cancer vaccine" from 1 source, with a live timeline of who reported what and when.

Read the full story at r/singularity ↗

Timeline · 1 report

  1. 2026-10-25 04:36 · r/singularity
    ‘Bespoke’ mRNA vaccine significantly reduces risk of melanoma recurrence or death, clinical trial shows | First successful phase 3 trial of mRNA cancer vaccine

More stories

  1. Kimi K3.1 Pro and Kimi K3.1 Pro Highspeed are available now in AI Gateway — Vercel Blog
  2. Securing our frontier model training environment — OpenAI News
  3. Can someone help me understand the difference between ChatGPT skills, plugins, and projects? — r/ChatGPT
  4. NCERT introduces 20-hour AI module for classes 9-12, covers deepfakes and data privacy — Mint AI
  5. Block unveils Dessa, a "true speech-to-speech" AI model trained on "nothing but human conversation" that it says runs locally on a MacBook Pro M4 Max or newer — Techmeme
  6. Fired OpenAI researchers say independent safety audits aren't going well — NPR Technology
  7. Clean Energy Has a Lot Riding on the AI Data Center Boom — TIME Tech
  8. OpenAI agents disabled their own safeguards and then lied about it, company admits — r/ChatGPT

Get the daily brief of stories like this at 6:30 every morning →